Maureen Bourner

452 total citations
11 papers, 378 citations indexed

About

Maureen Bourner is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Maureen Bourner has authored 11 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Maureen Bourner's work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and RNA modifications and cancer (2 papers). Maureen Bourner is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and RNA modifications and cancer (2 papers). Maureen Bourner collaborates with scholars based in United States, Germany and United Kingdom. Maureen Bourner's co-authors include Gwen G. Krivi, Walker H. Busby, Robert H. McCusker, David R. Clemmons, Edward J. Weinstein, Richard Mazzarella, Christopher J. Bauer, Hamideh Zakeri, David C. Thompson and Richard Head and has published in prestigious journals such as Cancer Letters, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Journal of Cellular Biochemistry.

In The Last Decade

Maureen Bourner

10 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Bourner United States 9 167 105 93 51 48 11 378
S.J. Mao United States 5 197 1.2× 111 1.1× 111 1.2× 102 2.0× 28 0.6× 6 506
Sandra Huling United States 11 204 1.2× 225 2.1× 29 0.3× 38 0.7× 19 0.4× 13 490
Robert Dullea United States 10 281 1.7× 54 0.5× 42 0.5× 16 0.3× 9 0.2× 14 479
Véronique Sbarra France 14 355 2.1× 115 1.1× 117 1.3× 66 1.3× 10 0.2× 22 679
Yuanyi Wei China 12 196 1.2× 76 0.7× 32 0.3× 21 0.4× 13 0.3× 29 349
B. Scaglione-Sewell United States 12 314 1.9× 179 1.7× 43 0.5× 61 1.2× 11 0.2× 16 576
Patrizia Griffini Italy 12 149 0.9× 74 0.7× 11 0.1× 26 0.5× 34 0.7× 21 429
Sachiko Kimura Japan 13 114 0.7× 96 0.9× 29 0.3× 34 0.7× 7 0.1× 38 365
Yoichiro Takami Japan 13 178 1.1× 33 0.3× 25 0.3× 25 0.5× 9 0.2× 25 385

Countries citing papers authored by Maureen Bourner

Since Specialization
Citations

This map shows the geographic impact of Maureen Bourner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Bourner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Bourner more than expected).

Fields of papers citing papers by Maureen Bourner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Bourner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Bourner. The network helps show where Maureen Bourner may publish in the future.

Co-authorship network of co-authors of Maureen Bourner

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Bourner. A scholar is included among the top collaborators of Maureen Bourner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Bourner. Maureen Bourner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bourner, Maureen, et al.. (2024). Prospective fecal microbiomic biomarkers for chronic wasting disease. Microbiology Spectrum. 12(3). e0375022–e0375022.
2.
Liu, Yang, Andrew E. Schriefer, Pankaj Kumar, et al.. (2022). M-CAMPTM: A Cloud-based Web Platform with a Novel Approach forSpecies-level Classification of 16S rRNA Microbiome Sequences. Current Bioinformatics. 18(1). 21–39. 2 indexed citations
3.
Li, Shuaizhang, Jinghua Zhao, Ruili Huang, et al.. (2017). Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity. PubMed. 11(1). 19–30. 36 indexed citations
4.
Qiu, Xi, Yueping Zhang, Tongtong Liu, et al.. (2016). Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury. Molecular Pharmaceutics. 13(4). 1206–1216. 41 indexed citations
5.
Sampson, Kathleen E., et al.. (2014). Zinc Finger Nuclease–Mediated Gene Knockout Results in Loss of Transport Activity for P-Glycoprotein, BCRP, and MRP2 in Caco-2 Cells. Drug Metabolism and Disposition. 43(2). 199–207. 28 indexed citations
6.
Brinker, Amanda E., et al.. (2012). Use of Zinc Finger Nuclease Technology to Knock Out Efflux Transporters in C2BBe1 Cells. Current Protocols in Toxicology. 52(1). Unit 23.2.–Unit 23.2.. 13 indexed citations
7.
Lin, Jules, Duna Raoof, Dafydd G. Thomas, et al.. (2004). L-Type Amino Acid Transporter-1 Overexpression and Melphalan Sensitivity in Barrett's Adenocarcinoma. Neoplasia. 6(1). 74–84. 59 indexed citations
8.
Weinstein, Edward J., Maureen Bourner, Richard Head, et al.. (2003). URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1637(3). 207–216. 65 indexed citations
10.
Gierse, James K., Verne A. Luckow, Leslie J. Askonas, et al.. (1993). High-Level Expression and Purification of Human Leukotriene A4 Hydrolase from Insect Cells Infected with a Baculovirus Vector. Protein Expression and Purification. 4(5). 358–366. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026